Article
Clinical implications of CYP2D6 genetic polymorphism during treatment with antipsychotic drugs.
Current drug targets - 1 Dec 2006
Dorado P, Berecz R, Peñas-Lledó E M, Cáceres M C, Llerena A
Abstract excerpt
CYP2D6 is described as the most relevant enzyme in the metabolism of many antipsychotic drugs. Its contribution to the interindividual differences in drug response is reviewed here highlighting its role in the kinetics of antipsychotic drugs and the occurrence of drug interactions. The activity of CYP2D6 is inherited as a monogenetic trait and the CYP2D6 gene appears highly polymorphic in humans. The polymorphic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
